Does Ozempic cause hair loss — and what is it doing to your skin?

It’s one of the most common worries I hear from patients on GLP-1 medications: the weight is coming off, and so is the hair — and the face in the mirror looks older, not younger. In two decades of practicing medicine, I’ve learned that the honest answer here matters more than the reassuring one, so let’s walk through what the research actually shows about hair shedding and skin changes on semaglutide, tirzepatide, and the rest of the GLP-1 family.

The hair loss signal is real — and the absolute risk is still low

Let’s give the trend its due, because the data is now solid. A 2026 meta-analysis of over 4,000 GLP-1 users found roughly a threefold higher risk of hair loss compared to placebo, and a large study in diabetes patients confirmed the elevated risk against other diabetes medications. But here’s the number that matters just as much: the event rate was about 4%. That means the overwhelming majority of people on these medications never experience meaningful shedding. Real signal, low absolute risk — both things are true, and pretending otherwise in either direction is dishonest.

It’s mostly the weight loss, not the drug

This is the part almost nobody explains. The shedding pattern is called telogen effluvium: rapid weight loss and a sharp drop in food intake act as a physiologic stressor that pushes a large fraction of hair follicles into their resting, shedding phase all at once. The shedding typically shows up two to four months after the stressor, it’s diffuse rather than patchy, and — this is the good news — it’s usually temporary, with recovery once weight stabilizes. The faster and larger the weight loss, the higher the risk. Appetite suppression also quietly starves the follicles: when you’re eating a fraction of what you used to, protein and key micronutrients often fall short. One caveat I take seriously: significant weight loss shifts your hormone landscape, and in some people that can unmask patterned, progressive hair loss — which is a different problem with different treatment, and worth catching early.

“Ozempic face” and the skin side of the story

The skin changes follow the same logic. Rapid loss of the fat layer under the skin — along with collagen and elastin — produces the hollowed, deflated look people call “Ozempic face,” plus loose, lax skin elsewhere. The biggest risk factors: older age, long-standing weight before treatment, very rapid loss, poor hydration, and inadequate protein. We covered the facial side in depth on our Ozempic face page, including how we restore volume properly when it happens. The takeaway is the same for skin as for hair: the medication isn’t attacking your face — the speed of the change is outrunning your body’s ability to remodel.

What actually helps — and what’s a waste of money

First, before blaming the medication: the shedding needs a workup, because thyroid problems, low iron, and vitamin D deficiency cause the exact same picture and are fixable. That’s lab work, not guesswork. Second, the pace of loss matters — a supervised, gradual trajectory with adequate protein and hydration protects both hair and skin, and it’s a big part of why we adjust our GLP-1 patients every month rather than mailing them a pen and wishing them luck. Third, be careful with the supplement aisle: biotin megadosing has essentially no evidence unless you’re truly deficient, and it can interfere with thyroid and cardiac lab tests — something most people selling it never mention. Where a real deficiency shows up on labs, we replace it with individualized support provided through our office. And when shedding needs more than time, there are legitimate prescription-strength options and regenerative treatments — our page on PRP for hair loss covers one we perform here — matched to your pattern at your visit, not bought off a shelf.

Measure, don’t guess

If your hair is shedding or your skin is changing on a GLP-1, don’t quit the medication in a panic and don’t buy a gummy. Get labs, get your nutrition and pace of loss reviewed, and get an honest look at whether this is the temporary, reversible kind or something that deserves targeted treatment. These medications carry real metabolic benefits — the goal is to keep them working for you while protecting your hair, your skin, and your results. That’s exactly what a supervised program is for, and it’s how we run ours. For the full risk picture, our GLP-1 side effects page is the place to start.

Text us at 480-485-2197 to schedule, or call. Quick response, real scheduling, no phone tree.

To Health and Wellness,
Dr. Tallman

References

  • BMJ, 2026 — GLP-1 receptor agonists and hair loss risk in type 2 diabetes, target trial emulation
  • Diabetes Research and Clinical Practice, 2026 — GLP-1 receptor agonists and hair loss, systematic review and meta-analysis
  • Aesthetic Plastic Surgery, 2026 — effects of GLP-1 receptor agonists on skin quality
  • Dermatologic Surgery, 2026 — GLP-1 receptor agonists in hair loss, clinical evidence and mechanisms
  • JAMA Dermatology, 2023 — safety and effectiveness of nutritional supplements for hair loss
  • Clinics in Dermatology, 2026 — integrating GLP-1 receptor agonists into dermatology practice
Scroll to Top